Diagnostic and Interventional Cardiology

Verseon’s scientific journey to highly promising therapeutic candidates for cardiovascular disease appears in European Journal of Medicinal Chemistry

Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias

December 14, 2022 — Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of ...

December 14, 2022

Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers

News | Cardiovascular Business

Corindus, A Siemens Healthineers Company, Is Now Siemens Healthineers Endovascular Robotics

December 14, 2022 — Corindus, A Siemens Healthineers Company, has been rebranded to Siemens Healthineers Endovascular ...

December 14, 2022

Series to feature leading experts discussing the current and future trends in the carotid treatment market

News | Stents Carotid

InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists

December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

December 13, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes.

News | Structural Heart

Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement

December 13, 2022 — Edwards Lifesciences Corporation announced that one-year results on patients treated in the single ...

December 13, 2022

Image courtesy of Intermountain Healthcare

News | Cardiovascular Clinical Studies

Study Finds Patients Without Standard Modifiable Heart Risk Factors Are Common and More Likely to Fare Better After Heart Attack Than Patients with Known Factors

December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients without ...

December 13, 2022

The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases.

News | Pacemakers

Global Pacemakers Market Set to Grow at 5.4% CAGR Over Next 3 Years

December 12, 2022 — The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between ...

December 12, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | Cardiovascular Business

Edwards Lifesciences Announces CEO Succession Plan

December 12, 2022 — Edwards Lifesciences Corporation announced that following regular succession planning discussions ...

December 12, 2022

US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.

News | Artificial Intelligence

Weill Cornell Medicine partners with Poland-based company Cardiomatics to investigate the relationship between HIV and heart rhythm disorders

December 12, 2022 — US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza ...

December 12, 2022

Clinical abstract focuses on value of PURE EP’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation

News | Cardiovascular Clinical Studies

BioSig’s PURE EP System Highlighted in the Journal of Atrial Fibrillation and Electrophysiology

December 9, 2022 — BioSig Technologies, Inc. an advanced digital signal processing technology company delivering ...

December 09, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.

News | Cardiovascular Clinical Studies

Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment

December 9, 2022 — The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a ...

December 09, 2022

News | Cardiovascular Clinical Studies

Ninerafaxstat Showcased at the 19th Annual Global Cardio Vascular Clinical Trialists (CVCT) Forum with Focus on the Potential in Non-obstructive Hypertrophic Cardiomyopathy

December 9, 2022 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

December 09, 2022

Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission

News | Remote Monitoring

With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives

December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of ...

December 08, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint

News | Cardiovascular Clinical Studies

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint

December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

December 08, 2022

Along with physician leaders and members, the society has helped the subspecialty officially join NRMP’s Medical Specialties Matching Program in 2025

News | SCAI

SCAI Leads the Way for Interventional Cardiology to Join “The Match”

December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical ...

December 08, 2022

News | Ultrasound Imaging

Butterfly Announces CEO Transition

December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

December 08, 2022